- The folks at Memorial Sloan-Kettering Cancer Center are studying the effects of Topical Dapsone 5% Gel; Moisturizer; oral antibiotics on Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma and Cetuximab-induced Papulopustular (Acneiform) Rash Who Have in individuals ages 18 years and older. This clinical trial is slated to start August 2013 and is expected to end circa August 2015.212-610-0079
|Recruiting||Mario Lacouture, MD||212-610-0079|
This study is officially titled, "A Phase III Randomized Double-blind Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT."
|Recruiting||Memorial Sloan-Kettering Cancer Center|
New York, New York, 10021
United States - map
|Mario Lacouture, MD||212-610-0079|
For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.